Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Acute leukaemia, Acute myeloid leukaemia (AML), Blood cancers, Leukaemia
Closed
Phase 1
This trial is looking at a new drug called RO5503781 for people with acute myeloid leukaemia (AML).
Recruitment start: 23 May 2013
Recruitment end: 17 July 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Mark Drummond
Experimental Cancer Medicine Centre (ECMC)
Roche Products Limited
Last reviewed: 30 Jul 2015
CRUK internal database number: 11658
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
